Infinity Laboratories Inc is categorized under Pathological Laboratories in Macon, GA and active since 1998.
Infinity Laboratories Inc was established in 1998, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Pathological Laboratories business, which does work in the B2C market, and is classified as a Pathological Laboratories, under code number 6215110 by the NAICS.
If you are seeking more information, feel free to contact Odilee Kelsey, Owner at the company’s single location by writing to 117 Parkwood Avenue, Macon, Georgia GA 31210 or by phoning (478) 750-7732. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Infinity Laboratories Inc |
| Contact Person: | Odilee Kelsey, Owner |
| Address: | 117 Parkwood Avenue, Macon, Georgia 31210 |
| Phone Number: | (478) 750-7732 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1998 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Pathological Laboratories |
| SIC Code: | 8071 |
| NAICS Code: | 6215110 |
| Share This Business: |
Infinity Laboratories Inc was started in 1998 to provide professional Pathological Laboratories under the SIC code 8071 and NAICS code 6215110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Odilee Kelsey, Owner for inquiries that concern Infinity Laboratories Inc by calling the company number (478) 750-7732, as your correspondence is most welcome. Additionally, the physical location of the single location of Infinity Laboratories Inc can be found at the coordinates 32.86311,-83.69041 as well as the street address 117 Parkwood Avenue in Macon, Georgia 31210.
For its online presence, you may visit Infinity Laboratories Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.